U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C8H10N2O4
Molecular Weight 198.176
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of MIMOSINE

SMILES

N[C@@H](CN1C=CC(=O)C(O)=C1)C(O)=O

InChI

InChIKey=WZNJWVWKTVETCG-YFKPBYRVSA-N
InChI=1S/C8H10N2O4/c9-5(8(13)14)3-10-2-1-6(11)7(12)4-10/h1-2,4-5,12H,3,9H2,(H,13,14)/t5-/m0/s1

HIDE SMILES / InChI

Description
Curator's Comment: description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/26610453 | https://www.ncbi.nlm.nih.gov/pubmed/10047457 | https://www.ncbi.nlm.nih.gov/pubmed/25957199

Mimosine or leucenol is an alkaloid, beta-3-hydroxy-4 pyridone amino acid. Mimosine is an effective inhibitor of DNA replication in mammalian cells. It blocks entry into S phase (late G1 phase), and suppress elongation of DNA replication (S phase). The chelation of iron seems to be one of the main modes of action of mimosine for cell cycle arrest. As an iron-chelating and cell cycle stopping agent, mimosine was tested in preclinical models of cancer, pulmonary fibrosis and iron overload.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
3.8 µM [IC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Anatomy of the primase-alpha DNA polymerase reaction accomplished by nucleoprotein complexes harboring an extrachromosomal DNA identical with avian myeloblastosis virus core-bound DNA: influencing by carbonyldiphosphonate, mimosine and butylphenyl deoxyguanosine-5'-triphosphate.
2001 Apr
Partial purification, characterization, and histochemical localization of fully latent desert truffle (Terfezia claveryi Chatin) polyphenol oxidase.
2001 Apr
Lymphoblasts already in the DNA synthesis phase of the cell cycle can be reversibly arrested at the R/G transition.
2001 Dec
MCM3AP, a novel acetyltransferase that acetylates replication protein MCM3.
2001 Feb
Prevention of entrance into G2 cell cycle phase by mimosine decreases locomotion of cells from the tumor cell line SW480.
2001 Jan
Kinetic analyses of mitochondrial 75selenium uptake in Trigonella foenum-graecum seedlings exposed to selenium and mimosine.
2001 Mar
Survivin exists in immunochemically distinct subcellular pools and is involved in spindle microtubule function.
2002 Feb 1
Homologous recombination induced by replication inhibition, is stimulated by expression of mutant p53.
2002 Jan 17
Inhibition of ultraviolet B (UVB) induced apoptosis in A431 cells by mimosine is not dependent on cell cycle arrest.
2002 Jul
Tuning up or down the UV-induced apoptosis in Chinese hamster ovary cells with cell cycle inhibitors.
2002 Jun
Ultraviolet-B-induced G1 arrest is mediated by downregulation of cyclin-dependent kinase 4 in transformed keratinocytes lacking functional p53.
2002 May
Ultraviolet light-induced apoptosis is associated with S-phase in primary human fibroblasts.
2002 Oct 1
Engineering bacterial competitiveness and persistence in the phytosphere.
2002 Sep
The mid genes of Rhizobium sp strain TAL1145 are required for degradation of mimosine into 3-hydroxy-4-pyridone and are inducible by mimosine.
2003 Feb
Protein 4.1N is required for translocation of inositol 1,4,5-trisphosphate receptor type 1 to the basolateral membrane domain in polarized Madin-Darby canine kidney cells.
2003 Feb 7
Latent HIV-1 reactivation in transgenic mice requires cell cycle -dependent demethylation of CREB/ATF sites in the LTR.
2003 Jan 24
Asynchronous replication timing of imprinted loci is independent of DNA methylation, but consistent with differential subnuclear localization.
2003 Mar 15
Progesterone receptor and the cell cycle modulate apoptosis in granulosa cells.
2004 Nov
Mimosine attenuates serine hydroxymethyltransferase transcription by chelating zinc. Implications for inhibition of DNA replication.
2005 Jan 7
Modulation of differentiation-related gene 1 expression by cell cycle blocker mimosine, revealed by proteomic analysis.
2005 Jul
Immediate transfection of patient-derived leukemia: a novel source for generating cell-based vaccines.
2005 Jun 21
Piperidones with activity against Plasmodium falciparum.
2006 Aug
Activation of the human FP prostanoid receptor disrupts mitosis progression and generates aneuploidy and polyploidy.
2006 Jan
Selective determination of mimosine and its dihydroxypyridinyl derivative in plant systems.
2006 Oct
The mitotic manipulation of cytotrophoblast differentiation in vitro.
2007 May-Jun
Patents

Sample Use Guides

In model of pulmonary fibrosis mimosine was administed at doses 25 and 50 mg/kg. Pulmonary fibrosis was induced by tracheal instillation of 5 mg/kg bleomycin. Mimosine was first dissolved in Tris-buffer at pH 8.9, and then pH was adjusted to 7.2 with 1 N HCl. Before administration, this solution was freshly diluted by 0.9% physiologic saline to achieve the required concentration. L-Mimosine was administered via subcutaneous injection once daily from day 1 to day 28 after BLM or saline treatment.
Route of Administration: Other
The effect of mimosine on asynchronously proliferating HeLa cells was analyzed by flow cytometry. HeLa-S3 cells were cultured as proliferating monolayers on 145-mm plates in DMEM, supplemented with 10% FCS, 10 U/ml penicillin, and 0.1 mg/ml streptomycin. Mimosine stock solution was prepared at 10 mM in DMEM and filtered through 20-mm filters. Synchronization of HeLa cells by mimosine was achieved by adding mimosine from the stock solution directly to the cells at the concentrations specified. Cell synchronization was determined by flow cytometry of isolated nuclei. One million nuclei were directly stained with propidium iodide (5 mg/ml in PBS containing 0.4% Triton X-100) and analyzed by FACScan (Becton Dickinson) using the Lysis II-software.
Name Type Language
MIMOSINE
MI  
Common Name English
Mimosine [WHO-DD]
Common Name English
NSC-69188
Code English
LEUCENOL
Common Name English
L-MIMOSINE
Common Name English
MIMOSIN
Common Name English
MIMOSINE [MI]
Common Name English
1(4H)-PYRIDINEPROPANOIC ACID, .ALPHA.-AMINO-3-HYDROXY-4-OXO-, (.ALPHA.S)-
Systematic Name English
LEUCAENOL
Common Name English
LEUCENINE
Common Name English
LEUCAENINE
Common Name English
Code System Code Type Description
CHEBI
29063
Created by admin on Sat Dec 16 09:40:23 GMT 2023 , Edited by admin on Sat Dec 16 09:40:23 GMT 2023
PRIMARY
DRUG CENTRAL
1811
Created by admin on Sat Dec 16 09:40:23 GMT 2023 , Edited by admin on Sat Dec 16 09:40:23 GMT 2023
PRIMARY
FDA UNII
Z46B1LUI5N
Created by admin on Sat Dec 16 09:40:23 GMT 2023 , Edited by admin on Sat Dec 16 09:40:23 GMT 2023
PRIMARY
PUBCHEM
440473
Created by admin on Sat Dec 16 09:40:23 GMT 2023 , Edited by admin on Sat Dec 16 09:40:23 GMT 2023
PRIMARY
EPA CompTox
DTXSID401017244
Created by admin on Sat Dec 16 09:40:23 GMT 2023 , Edited by admin on Sat Dec 16 09:40:23 GMT 2023
PRIMARY
DRUG BANK
DB01055
Created by admin on Sat Dec 16 09:40:23 GMT 2023 , Edited by admin on Sat Dec 16 09:40:23 GMT 2023
PRIMARY
ECHA (EC/EINECS)
207-905-1
Created by admin on Sat Dec 16 09:40:23 GMT 2023 , Edited by admin on Sat Dec 16 09:40:23 GMT 2023
PRIMARY
MERCK INDEX
m7550
Created by admin on Sat Dec 16 09:40:23 GMT 2023 , Edited by admin on Sat Dec 16 09:40:23 GMT 2023
PRIMARY Merck Index
NSC
69188
Created by admin on Sat Dec 16 09:40:23 GMT 2023 , Edited by admin on Sat Dec 16 09:40:23 GMT 2023
PRIMARY
HSDB
3512
Created by admin on Sat Dec 16 09:40:23 GMT 2023 , Edited by admin on Sat Dec 16 09:40:23 GMT 2023
PRIMARY
CHEBI
77689
Created by admin on Sat Dec 16 09:40:23 GMT 2023 , Edited by admin on Sat Dec 16 09:40:23 GMT 2023
PRIMARY
CAS
500-44-7
Created by admin on Sat Dec 16 09:40:23 GMT 2023 , Edited by admin on Sat Dec 16 09:40:23 GMT 2023
PRIMARY